These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 999265)

  • 21. Unusual multiresistant Vibrio cholerae O1 El Tor in Argentina.
    Rossi A; Galas M; Binztein N; Rivas M; Caffer MI; Corso A; Radice M; Gutkind G
    Lancet; 1993 Nov; 342(8880):1172-3. PubMed ID: 7901493
    [No Abstract]   [Full Text] [Related]  

  • 22. Emergence of multiple drug resistance in Vibrio cholerae O1 El Tor from Ecuador.
    Threlfall EJ; Said B; Rowe B
    Lancet; 1993 Nov; 342(8880):1173. PubMed ID: 7901494
    [No Abstract]   [Full Text] [Related]  

  • 23. [Accelerated radioisotope method of determining cholera vibrios' sensitivity to antibiotics].
    Korol' VV; Podosinnikova LS; Golubinskiĭ EP; Rublev BD
    Antibiotiki; 1980 May; 25(5):353-6. PubMed ID: 7387130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with enteritis in Ceará, Brazil.
    Hofer E; Reis EM; Quintaes BR; Rodrigues DP; Feitosa IS; Angelo MR; Ribeiro LH
    J Health Popul Nutr; 2001 Mar; 19(1):39-42. PubMed ID: 11394182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug resistance in Vibrio cholerae.
    Anand VK; Arora S; Patwari AK; Agarwal GD; Dewan N
    Indian Pediatr; 1996 Sep; 33(9):774-7. PubMed ID: 9057408
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro anti-Vibrio cholerae activity of essential oil from Lepechinia caulescens.
    Acevedo JG; López JL; Cortés AM; Bores AM; Cortés GM; Castro IP
    Fitoterapia; 2005 Jan; 76(1):104-7. PubMed ID: 15664471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of the sensitivity of NAG-Vibrio to antibiotics by the methods of serial dilution in agar and agar diffusion].
    Givental' NI; Razvykh VM; Ved'mina EA; Ogneva NS; Bogdanova LF
    Antibiotiki; 1982; 27(12):18-22. PubMed ID: 7165291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India.
    Jain M; Kumar P; Goel AK; Kamboj DV; Singh L
    Int J Antimicrob Agents; 2008 Nov; 32(5):459-60. PubMed ID: 18706789
    [No Abstract]   [Full Text] [Related]  

  • 29. [Compatibility groups of resistance plasmids from Gram negative bacteria isolated in Algeria ].
    Rahal K
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):539-42. PubMed ID: 6750522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inc J plasmids identified for the first time in Vibrio cholerae El Tor].
    Korichi MN; Belhocine S; Rahal K
    Med Trop (Mars); 1997; 57(3):249-52. PubMed ID: 9513150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacteriological aspects of cholera in Benin (epidemic of 1991)].
    Anagonou SY; Josse R; Foundohou J; Helynck B; Massougbodji A; Sadeler BC
    Bull Soc Pathol Exot; 1993; 86(5):333-5. PubMed ID: 8124099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple antibiotic resistance profiles of Vibrio cholerae non-O1 and non-O139.
    Kumar PA; Patterson J; Karpagam P
    Jpn J Infect Dis; 2009 May; 62(3):230-2. PubMed ID: 19468189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vibrio cholerae non-O1 as a causal pathogen in cholera patients in Yangon, Myanmar.
    Oo KN; Than WM; Win T; Thida M; Aung KS
    J Diarrhoeal Dis Res; 1995 Sep; 13(3):176-9. PubMed ID: 8568194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Features of Vibrio cholerae 0:1 El Tor, Inaba serotype, isolated during the cholera epidemic in Cartagena (Colombia)].
    Salim Máttar V
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):525-30. PubMed ID: 1489792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholera epidemic in and around Loni a rural area in western Maharashtra.
    Gujrathi UP; Sivarajan K; Kulkarni SG
    Indian J Pathol Microbiol; 2000 Jan; 43(1):101-2. PubMed ID: 12583433
    [No Abstract]   [Full Text] [Related]  

  • 36. [The chemosensitivity of strains of Vibrio cholerae group O1 isolated in Romania between 1977-1995].
    Israil A; Năcescu N; Cedru C; Balotescu C
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(4):213-20. PubMed ID: 9586330
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antibiotic susceptibility of Vibrio cholerae 01: evolution after prolonged curative and preventive use during the 2004 cholera epidemics in Douala (Cameroon)].
    Guévart E; Solle J; Mouangue A; Noeske J; Bita A; Fonkoua MC; Ndayo Wouafo M
    Med Mal Infect; 2006 Jun; 36(6):329-34. PubMed ID: 16757139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The status of antibiotic sensitivity of Vibrio cholerae 0:1 in Ecuador].
    Aldighieri S; Vela E; Pesantes C
    Med Trop (Mars); 1997; 57(1):98. PubMed ID: 9289622
    [No Abstract]   [Full Text] [Related]  

  • 39. The in vitro activity of Midecamycin against various Vibrio species.
    Bonang G; Surjawidjaja JE; Santoso US
    Jpn J Exp Med; 1975 Feb; 45(1):43-5. PubMed ID: 1228226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outbreak of cholera caused by Vibrio cholerae 01 intermediately resistant to norfloxacin at Malda, West Bengal.
    Bhattacharya MK; Ghosh S; Mukhopadhyay AK; Deb A; Bhattacharya SK
    J Indian Med Assoc; 2000 Jul; 98(7):389-90. PubMed ID: 11143861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.